末梢血管デバイス市場規模、シェア、動向、2031年までの世界予測

末梢血管デバイス市場は、2026年の100億2000万米ドルから2031年には132億2000万米ドルに達するとMarketsandMarketsでは予測しており、2026年から2031年までの年平均成長率は5.7%となる見込みです。

末梢血管デバイス市場は、末梢動脈疾患（PAD）をはじめとする血管疾患の罹患率の上昇を背景に、著しい成長を遂げています。これらの疾患は、高齢化に加え、糖尿病、肥満、喫煙率の上昇と密接に関連しています。薬剤溶出バルーン、次世代ステント、アテレクトミーシステム、塞栓防止デバイスといった低侵襲血管内デバイスの革新は、臨床成績を大幅に向上させ、治療可能な患者層を拡大させています。さらに、多くの地域で有利な診療報酬制度に支えられた外来および日帰り手術センターでの処置への嗜好の高まりも、これらのデバイスの普及を加速させています。

調査概要

本レポートは、末梢血管デバイス市場を分析し、様々なセグメントにおける市場規模と将来の成長可能性を推定しています。これらのセグメントには、血管形成術用ステント、血管内動脈瘤修復用ステントグラフト、下大静脈フィルター、カテーテル、血管形成術用バルーン、プラーク修飾デバイス、血行動態流量調整デバイス、その他のデバイス、およびエンドユーザーが含まれます。さらに、本レポートには、市場で入手可能な様々な末梢血管デバイスの製品ポートフォリオマトリックスが含まれています。また、主要企業の競合分析も提供しており、各社の企業概要、製品ラインナップ、主要な市場戦略を詳細に解説しています。

本レポートを購入する理由

本レポートは、市場リーダーおよび新規参入企業に対し、末梢血管デバイス市場全体およびそのサブセグメントにおける貴重な収益予測を提供します。関係者は、本レポートを通じて競争環境を理解し、自社の事業をより効果的に位置づけ、効果的な市場参入戦略を策定することができます。さらに、本レポートでは、現在の市場動向に関する洞察を提供し、主要な推進要因、阻害要因、課題、機会を明らかにします。

本レポートは、以下のポイントに関する洞察を提供します。

• 主要な推進要因（高齢者人口の急速な増加とそれに伴う疾患罹患率の上昇、末梢血管処置に対する有利な償還制度）、阻害要因（代替治療法の存在、末梢血管デバイスに関する専門知識を有する熟練専門家の不足）、機会（新興市場における高い成長可能性、肥満および糖尿病の罹患率の上昇）、課題（製品の不具合およびデバイスのリコール）の分析。
• 製品開発／改良：世界の末梢血管デバイス市場における新製品の発売と予測されるトレンドに関する包括的な詳細情報。
• 製品イノベーション：世界の末梢血管デバイス市場における今後のトレンド、研究開発活動、および新製品の発売に関する詳細な洞察。
• 市場開発：血管形成術用ステント、構造的心臓デバイス、カテーテル、血管形成術用バルーン、プラーク修飾デバイス、血行動態フロー改変デバイス、その他のデバイス、およびエンドユーザー別の有望な新興市場に関する包括的な情報。
• 市場の多様化：世界の末梢血管デバイス市場における新製品・サービス、製品・サービスの改良、成長地域、最新動向、投資に関する包括的な情報。
• 競合評価：世界の末梢血管デバイス市場における主要競合企業の市場シェア、成長戦略、製品・サービスの提供内容、生産能力を徹底的に評価。

Report Description

The peripheral vascular devices market is projected to reach USD 13.22 billion by 2031 from USD 10.02 billion in 2026, at a CAGR of 5.7% from 2026 to 2031.

The peripheral vascular devices market is experiencing significant growth, driven by the rising prevalence of peripheral artery disease (PAD) and other vascular disorders. These conditions are largely linked to the aging population, along with rising rates of diabetes, obesity, and smoking. Innovations in minimally invasive endovascular devices, such as drug-coated balloons, next-generation stents, atherectomy systems, and embolic protection devices, are greatly improving clinical outcomes and expanding the range of patients who can be treated. Additionally, the growing preference for outpatient and ambulatory surgical center-based procedures, supported by favorable reimbursement policies in many regions, is accelerating the adoption of these devices.

Furthermore, increasing awareness of early diagnosis and treatment, improvements in healthcare infrastructure in developing countries, and ongoing investments by major manufacturers in innovation and clinical research are all contributing to market growth.

“The old/normal balloons segment is expected to grow at the highest CAGR in the angioplasty balloons market during the forecast period.”

The angioplasty balloons market is experiencing increased demand for plain (standard) balloons due to their cost-effectiveness, availability of clinical expertise, and versatility across peripheral and coronary interventions. These balloons remain popular for lesion preparation, as well as for pre- and post-dilatation procedures, particularly when drug-coated options are either unnecessary or not covered by insurance. Despite the emergence of advanced balloon technologies, standard balloons continue to see strong sales in less demanding, high-volume markets, especially in developing countries, due to their ease of use, reliability, and compatibility with different stent systems.

“The embolic protection devices segment is expected to grow at the highest CAGR in the hemodynamic flow alteration devices market during the forecast period.”

Embolic protection devices are expected to see increased demand in the hemodynamic flow alteration devices market. This is due to their growing use in complex endovascular and structural heart procedures, where the risk of distal embolization is notably high. The rising awareness of procedure-related complications, such as stroke and organ ischemia—especially during carotid, peripheral, and transcatheter interventions—has accelerated their clinical adoption. Additionally, improvements in device design, which enhance capture efficiency, deliverability, and vessel compatibility, have significantly supported market growth. This trend is further bolstered by the introduction of established guidelines and the expansion of minimally invasive vascular procedures.

“Based on end users, the ambulatory surgical centers segment is expected to grow at the highest CAGR in the peripheral vascular devices market during the forecast period.”

The peripheral vascular devices market is experiencing significant growth, largely driven by the positive impact of ambulatory surgery centers (ASCs). These centers facilitate the shift toward minimally invasive procedures that prioritize the comfort and safety of outpatient care. ASCs offer numerous benefits, including lower procedural costs, faster patient turnover, shorter hospital stays, and improved operational efficiency, making them appealing to payers, providers, and patients alike. Innovations in peripheral vascular devices, such as miniaturized imaging systems, low-profile catheters, balloons, and atherectomy devices, have enabled even the most complex procedures to be performed in ASC settings. Additionally, favorable reimbursement policies, physician ownership models, increasing patient preference for same-day discharge, and the rising incidence of peripheral artery disease (PAD) are all contributing to the accelerated adoption of ASCs in this market.

“The Asia Pacific is estimated to register the highest CAGR during the forecast period.”

The primary driver of the peripheral vascular devices market in the APAC region is the rapidly increasing incidence of peripheral artery disease (PAD) and diabetes. This trend is supported by a large aging population and a global shift towards healthier lifestyles. Countries like China, India, and Japan are leading the way in adopting these devices, driven by developing healthcare infrastructure, rising healthcare expenditures, and improved access to advanced endovascular procedures. Additionally, growing awareness of the benefits of minimally invasive interventions, an increasing number of skilled interventional specialists, and a gradual but steady expansion of reimbursement coverage in key markets are also contributing to market growth. Furthermore, low-cost manufacturing, the presence of local companies, and the strategic expansion of global medical device firms are significant drivers of this market’s growth in the APAC region.

Key Players

Some of the major players in this market are Boston Scientific (US), Medtronic Plc (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Merit Medical Systems (US), Penumbra, Inc. (US), Koninklijke Philips (Netherlands), Stryker (US), Cordis (US), W.L. Gore & Associates (US), Biotronik Stryker (US), Endologix LLC (US), and Cook Medical (US), among others.

Research Coverage

The report analyzes the peripheral vascular devices market, estimating market size and future growth potential across various segments. These segments include angioplasty stents, endovascular aneurysm repair stent grafts, inferior vena cava filters, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users. Additionally, the report includes a product portfolio matrix of various peripheral vascular devices available in the market. It also provides a competitive analysis of the key players in this market, detailing their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

This report will provide market leaders and new entrants with valuable revenue estimates for the overall peripheral vascular devices market and its subsegments. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report will offer insights into the current market dynamics, highlighting key drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rapid growth in geriatric population and resulting increase in disease prevalence and favorable reimbursement scenario for peripheral vascular procedures), restraints (availability of alternative treatment options and shortage of skilled professionals with expertise in peripheral vascular devices), opportunities (high growth potential in emerging markets and growing incidence of obesity & diabetes), and challenges (product failures and device recalls).
• Product Developments/Enhancements: Comprehensive details about new product launches and anticipated trends in the global peripheral vascular devices market.
• Product Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global peripheral vascular devices market.
• Market Development: Comprehensive information on the lucrative emerging markets by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users.
• Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global peripheral vascular devices market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global peripheral vascular devices market.

Table of Contents

1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.3 MARKET SCOPE 38
1.3.1 MARKET SEGMENTATION 38
1.3.2 INCLUSIONS & EXCLUSIONS 39
1.3.3 YEARS CONSIDERED 39
1.3.4 CURRENCY CONSIDERED 39
1.4 MARKET STAKEHOLDERS 40
1.5 SUMMARY OF CHANGES 41
2 EXECUTIVE SUMMARY 42
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 42
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 43
2.3 DISRUPTIVE TRENDS IN PERIPHERAL VASCULAR DEVICES MARKET 44
2.4 HIGH GROWTH SEGMENTS 45
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 46
3 PREMIUM INSIGHTS 47
3.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW 47
3.2 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE
AND COUNTRY 48
3.3 PERIPHERAL VASCULAR DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
3.4 PERIPHERAL VASCULAR DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 49
4 MARKET OVERVIEW 50
4.1 INTRODUCTION 50
4.2 MARKET DYNAMICS 50
4.2.1 DRIVERS 51
4.2.1.1 Rapid growth in geriatric population 51
4.2.1.2 Favorable reimbursement scenario for procedures 51
4.2.1.3 Increasing number of product approvals 52
4.2.1.4 Rising prevalence of diabetes 53
4.2.1.5 Growth in tobacco consumption 53
4.2.1.6 Rising obesity rates 54
4.2.2 RESTRAINTS 55
4.2.2.1 Increasing number of product failures and recalls 55
4.2.2.2 Regulatory complexity and approval delays 56

4.2.3 OPPORTUNITIES 57
4.2.3.1 High growth potential in emerging markets 57
4.2.3.2 Increasing awareness and early diagnosis of PAD 57
4.2.4 CHALLENGES 58
4.2.4.1 Limited availability of alternative treatments 58
4.2.4.2 Dearth of skilled professionals with expertise in peripheral vascular devices 58
4.3 UNMET NEEDS AND WHITE SPACES 59
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 60
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61
5 INDUSTRY TRENDS 62
5.1 PORTER’S FIVE FORCES ANALYSIS 62
5.1.1 THREAT OF NEW ENTRANTS 63
5.1.2 THREAT OF SUBSTITUTES 64
5.1.3 BARGAINING POWER OF SUPPLIERS 65
5.1.4 BARGAINING POWER OF BUYERS 65
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.2 MACROECONOMICS INDICATORS 66
5.2.1 INTRODUCTION 66
5.2.2 GDP TRENDS AND FORECAST 66
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 67
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 67
5.3 SUPPLY CHAIN ANALYSIS 68
5.4 VALUE CHAIN ANALYSIS 69
5.5 ECOSYSTEM ANALYSIS 70
5.6 PRICING ANALYSIS 71
5.6.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS,
2023–2025 71
5.6.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023–2025 72
5.7 TRADE ANALYSIS 73
5.7.1 IMPORT DATA FOR HS CODE 901839 73
5.7.2 EXPORT DATA FOR HS CODE 901839 75
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 77
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 78
5.10 INVESTMENT AND FUNDING SCENARIO 78
5.11 CASE STUDY ANALYSIS 79
5.11.1 MEDTRONIC 79
5.11.2 TERUMO 80
5.11.3 BOSTON SCIENTIFIC CORPORATION 80

5.12 IMPACT OF 2025 US TARIFFS – PERIPHERAL VASCULAR DEVICES MARKET 81
5.12.1 INTRODUCTION 81
5.12.2 KEY TARIFF RATES 81
5.12.3 PRICE IMPACT ANALYSIS 82
5.12.4 IMPACT ON COUNTRIES/REGIONS 83
5.12.4.1 US 83
5.12.4.2 Europe 83
5.12.4.3 Asia Pacific 83
5.12.5 IMPACT ON END-USE INDUSTRIES 84
5.12.5.1 Hospitals 84
5.12.5.1.1 Large chain hospitals 84
5.12.5.1.2 Standalone hospital facilities 84
5.12.5.2 Ambulatory care settings 84
5.12.5.3 Cardiac care centers 85
5.12.5.4 Other end users 85
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 86
6.1 TECHNOLOGY ANALYSIS 86
6.1.1 KEY EMERGING TECHNOLOGIES 86
6.1.1.1 Drug-eluting stents 86
6.1.1.2 Atherectomy devices 86
6.1.2 COMPLEMENTARY TECHNOLOGIES 87
6.1.2.1 Intravascular ultrasound 87
6.1.2.2 Optical coherence tomography 88
6.1.3 ADJACENT TECHNOLOGIES 88
6.1.3.1 Remote patient monitoring 88
6.1.3.2 3D printing and patient-specific modeling 89
6.2 TECHNOLOGY/PRODUCT ROADMAP 89
6.3 PATENT ANALYSIS 90
6.3.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS AND JURISDICTION FOR PERIPHERAL VASCULAR DEVICES MARKET, JANUARY 2015–DECEMBER 2025 90
6.3.2 LIST OF MAJOR PATENTS, 2023–2026 92
6.4 FUTURE APPLICATIONS 94
6.4.1 INTRAVASCULAR LITHOTRIPSY FOR CALCIFIED PAD LESIONS 94
6.4.2 ADVANCED IMAGE-GUIDED INTERVENTIONS 94
6.4.3 SMART SENSOR-INTEGRATED VASCULAR IMPLANTS 94
6.4.4 INTEGRATED MULTI-FUNCTION ENDOVASCULAR DEVICES 94
6.5 IMPACT OF AI ON PERIPHERAL VASCULAR DEVICES MARKET 95

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 96
7.1 REGULATIONS AND COMPLIANCE 96
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
7.1.2 INDUSTRY STANDARDS 99
7.1.2.1 Medical Device Quality Management Standard (ISO 13485) 99
7.1.2.2 Biological Evaluation and Biocompatibility of Medical Devices
(ISO 10993) 99
7.1.2.3 Vascular Stent Performance Standard (ISO 25539-2) 99
7.1.2.4 Intravascular Access Device Standard (ISO 11070) 100
7.2 SUSTAINABILITY INITIATIVES 100
7.2.1 SUSTAINABLE PACKAGING AND DIGITAL INSTRUCTIONS
(BOSTON SCIENTIFIC CASE STUDY) 100
7.2.2 SUSTAINABLE PRODUCT LIFECYCLE MANAGEMENT (ABBOTT CASE STUDY) 100
7.2.3 PACKAGING WASTE REDUCTION INITIATIVE BY MEDTRONIC 101
7.3 CERTIFICATIONS, LABELING, ECO-STANDARDS 101
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 102
8.1 DECISION-MAKING PROCESS 102
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 103
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 103
8.2.2 BUYING CRITERIA 104
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 105
8.4 UNMET NEEDS IN VARIOUS END-USE SETTINGS 106
8.5 MARKET PROFITABILITY 106
8.5.1 SHIFT TOWARD HIGH-VALUE, DRUG-ELUTING, AND SPECIALTY DEVICES 106
8.5.2 PROCEDURE VOLUME GROWTH DRIVEN BY AGING POPULATION AND PAD PREVALENCE 106
8.5.3 COST OPTIMIZATION THROUGH SUPPLY CHAIN EFFICIENCY AND PORTFOLIO BREADTH 107
9 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 108
9.1 INTRODUCTION 109
9.2 ANGIOPLASTY STENTS MARKET, BY TYPE 110
9.2.1 VOLUME ANALYSIS: ANGIOPLASTY STENTS MARKET, BY TYPE 110
9.2.2 DRUG-ELUTING STENTS 112
9.2.2.1 Drug-eluting stents to witness higher adoption due to technological advancements leading to lower restenosis rate 112
9.2.3 BARE-METAL STENTS 114
9.2.3.1 Bare-metal stents, by delivery platform 116
9.2.3.1.1 Balloon-expandable stents 116
9.2.3.1.1.1 Better radial strength and ease of deployment to drive usage 116

9.2.3.1.2 Self-expandable stents 118
9.2.3.1.2.1 Flexibility, tolerance, and support for vessel movement and compression to propel market 118
9.3 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE 120
9.3.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS 122
9.3.1.1 Rising prevalence of AAA and need for less invasive treatment to drive market 122
9.3.2 THORACIC AORTIC ANEURYSM STENT GRAFTS 124
9.3.2.1 Increasing incidence of thoracic aortic aneurysms to propel adoption 124
9.4 CATHETERS MARKET, BY TYPE 126
9.4.1 ANGIOGRAPHY CATHETERS 128
9.4.1.1 Angiography catheters to dominate catheters market 128
9.4.2 GUIDING CATHETERS 130
9.4.2.1 Growing number of target procedures to drive demand for guiding catheters 130
9.4.3 IVUS/OCT CATHETERS 132
9.4.3.1 IVUS/OCT catheters segment to register highest growth 132
9.5 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE 134
9.5.1 RETRIEVABLE FILTERS 136
9.5.1.1 Retrievable filters segment to register higher growth due to increase in use as temporary measure to block pulmonary embolism 136
9.5.2 PERMANENT FILTERS 138
9.5.2.1 Advances in other technologies and risks associated with permanent filters to hamper sales 138
9.6 ANGIOPLASTY BALLOONS MARKET, BY TYPE 140
9.6.1 OLD/NORMAL BALLOONS 142
9.6.1.1 Old/normal balloons to dominate angioplasty balloons market as they remain effective and widely used 142
9.6.2 DRUG-ELUTING BALLOONS 144
9.6.2.1 Drug-eluting balloons to witness highest growth with increasing demand for angioplasty procedures and rising regulatory approvals for DEBs 144
9.6.3 CUTTING & SCORING BALLOONS 146
9.6.3.1 Preference for medication as primary treatment for atherosclerosis to restrain adoption 146
9.7 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 148
9.7.1 ATHERECTOMY DEVICES 150
9.7.1.1 Increase in incidence of atherosclerosis to drive market 150
9.7.2 THROMBECTOMY DEVICES 152
9.7.2.1 Growing DVT incidence to drive adoption of thrombectomy devices 152
9.8 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 154
9.8.1 EMBOLIC PROTECTION DEVICES 156
9.8.1.1 Investments in technological advancements and growing regulatory approvals to drive market 156

9.8.2 CHRONIC TOTAL OCCLUSION DEVICES 158
9.8.2.1 Rise in support for device development especially in addressing longstanding plaque buildup to drive market 158
9.9 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 160
9.9.1 GUIDEWIRES 162
9.9.1.1 Higher success rate during stenting and endovascular aneurysm repair contribute to largest market share 162
9.9.2 VASCULAR CLOSURE DEVICES 164
9.9.2.1 Technological advancements and minimized duration of hospital stay to support demand 164
9.9.3 INTRODUCER SHEATHS 166
9.9.3.1 Potential for reducing arterial damage during interventional procedures to drive adoption 166
9.9.4 BALLOON INFLATION DEVICES 168
9.9.4.1 Integrated technologies and rising number of target procedures to propel adoption 168
10 PERIPHERAL VASCULAR DEVICES MARKET, BY END USER 170
10.1 INTRODUCTION 171
10.2 HOSPITALS 171
10.2.1 ADVANCED INFRASTRUCTURE AND SPECIALIZED EQUIPMENT TO DRIVE SEGMENT GROWTH 171
10.2.2 LARGE CHAIN HOSPITALS 174
10.2.2.1 Strong infrastructure and integrated networks driving dominance in complex peripheral vascular procedures 174
10.2.3 STANDALONE HOSPITAL FACILITIES 176
10.2.3.1 Expanding accessibility and cost-effective care to support peripheral vascular procedure volumes 176
10.3 AMBULATORY SURGICAL CENTERS 178
10.3.1 FASTER PROCEDURE TIME AND LOWER INFECTION RATES TO DRIVE SEGMENT GROWTH 178
10.4 OTHER END USERS 180
11 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 182
11.1 INTRODUCTION 183
11.2 NORTH AMERICA 184
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 184
11.2.2 NORTH AMERICA ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS,
BY TYPE 186
11.2.3 US 190
11.2.3.1 Favorable reimbursement scenario to contribute to market growth 190
11.2.4 CANADA 195
11.2.4.1 Increasing cases of chronic conditions to fuel market 195

11.3 EUROPE 200
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 200
11.3.2 EUROPE ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE 202
11.3.3 GERMANY 206
11.3.3.1 Statutory health insurance policy to support market growth 206
11.3.4 FRANCE 211
11.3.4.1 Growing geriatric population to drive market 211
11.3.5 UK 216
11.3.5.1 Increasing volume of coronary angioplasty procedures to sustain market growth 216
11.3.6 SPAIN 221
11.3.6.1 Growing cases of diabetes and obesity to boost market 221
11.3.7 ITALY 226
11.3.7.1 Increasing prevalence of atherosclerotic cardiovascular disease to spur market growth 226
11.3.8 REST OF EUROPE 231
11.4 ASIA PACIFIC 236
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 237
11.4.2 ASIA PACIFIC ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE 239
11.4.3 JAPAN 243
11.4.3.1 Large geriatric population to ensure sustained demand 243
11.4.4 CHINA 248
11.4.4.1 Growing incidence of lifestyle diseases to fuel market 248
11.4.5 INDIA 253
11.4.5.1 Rising prevalence of target diseases and growing healthcare expenditure to propel market 253
11.4.6 AUSTRALIA 258
11.4.6.1 High prevalence of cardiovascular and peripheral artery diseases to drive market 258
11.4.7 SOUTH KOREA 263
11.4.7.1 Rising rates of chronic diseases to boost market 263
11.4.8 REST OF ASIA PACIFIC 268
11.5 LATIN AMERICA 272
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 273
11.5.2 LATIN AMERICA ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE 275
11.5.3 BRAZIL 278
11.5.3.1 Rising healthcare expenditure to aid market growth 278
11.5.4 MEXICO 283
11.5.4.1 Increasing prevalence of cardiovascular diseases to spur market growth 283
11.5.5 COLOMBIA 288
11.5.5.1 Growing incidence of peripheral artery diseases to expedite market growth 288

11.5.6 ARGENTINA 293
11.5.6.1 Increasing prevalence of peripheral artery diseases to support market growth 293
11.5.7 REST OF LATIN AMERICA 298
11.6 MIDDLE EAST & AFRICA 303
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 303
11.6.2 MIDDLE EAST & AFRICA ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE 305
11.6.3 GCC COUNTRIES 309
11.6.3.1 Kingdom of Saudi Arabia (KSA) 314
11.6.3.1.1 Rising diabetes prevalence and strong government healthcare investments to drive market 314
11.6.3.2 United Arab Emirates (UAE) 319
11.6.3.2.1 Advanced healthcare infrastructure and growing medical tourism to accelerate peripheral vascular devices adoption 319
11.6.4 REST OF GCC COUNTRIES 324
11.6.5 REST OF MIDDLE EAST & AFRICA 328
12 COMPETITIVE LANDSCAPE 334
12.1 INTRODUCTION 334
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 334
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 334
12.3 REVENUE ANALYSIS 336
12.4 MARKET SHARE ANALYSIS 336
12.4.1 GLOBAL: PERIPHERAL VASCULAR DEVICES MARKET SHARE ANALYSIS, 2025 337
12.4.2 US: PERIPHERAL VASCULAR DEVICES MARKET SHARE ANALYSIS, 2025 339
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 339
12.5.1 STARS 339
12.5.2 EMERGING LEADERS 339
12.5.3 PERVASIVE PLAYERS 339
12.5.4 PARTICIPANTS 340
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 341
12.5.5.1 Company footprint 341
12.5.5.2 Regional footprint 342
12.5.5.3 Product type footprint 343
12.5.5.4 End user footprint 344
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 345
12.6.1 PROGRESSIVE COMPANIES 345
12.6.2 DYNAMIC COMPANIES 345
12.6.3 RESPONSIVE COMPANIES 345
12.6.4 STARTING BLOCKS 345
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 347

12.7 BRAND/PRODUCT COMPARISON 349
12.8 COMPANY VALUATION AND FINANCIAL METRICS 349
12.8.1 FINANCIAL METRICS 349
12.8.2 COMPANY VALUATION 350
12.9 COMPETITIVE SCENARIO 350
12.9.1 PRODUCT LAUNCHES AND APPROVALS 351
12.9.2 DEALS 352
13 COMPANY PROFILES 355
13.1 KEY PLAYERS 355
13.1.1 BOSTON SCIENTIFIC CORPORATION 355
13.1.1.1 Business overview 355
13.1.1.2 Products offered 356
13.1.1.3 Recent developments 358
13.1.1.3.1 Product approvals 358
13.1.1.3.2 Deals 359
13.1.1.3.3 Other developments 360
13.1.1.4 MnM view 360
13.1.1.4.1 Right to win 360
13.1.1.4.2 Strategic choices 360
13.1.1.4.3 Weaknesses and competitive threats 360
13.1.2 BECTON, DICKINSON AND COMPANY 361
13.1.2.1 Business overview 361
13.1.2.2 Products offered 362
13.1.2.3 Recent developments 364
13.1.2.3.1 Product launches and approvals 364
13.1.2.3.2 Deals 365
13.1.2.3.3 Expansions 366
13.1.2.3.4 Other developments 366
13.1.2.4 MnM view 367
13.1.2.4.1 Right to win 367
13.1.2.4.2 Strategic choices 367
13.1.2.4.3 Weaknesses and competitive threats 367
13.1.3 ABBOTT LABORATORIES 368
13.1.3.1 Business overview 368
13.1.3.2 Products offered 369
13.1.3.3 Recent developments 371
13.1.3.3.1 Product launches 371
13.1.3.3.2 Deals 372
13.1.3.3.3 Expansions 372

13.1.3.4 MnM view 373
13.1.3.4.1 Right to win 373
13.1.3.4.2 Strategic choices made 373
13.1.3.4.3 Weaknesses and competitive threats 373
13.1.4 CARDINAL HEALTH, INC. 374
13.1.4.1 Business overview 374
13.1.4.2 Products offered 375
13.1.4.3 Recent developments 377
13.1.4.3.1 Product launches 377
13.1.4.3.2 Deals 377
13.1.4.3.3 Expansions 378
13.1.4.4 MnM view 378
13.1.4.4.1 Right to win 378
13.1.4.4.2 Strategic choices 379
13.1.4.4.3 Weaknesses and competitive threats 379
13.1.5 KONINKLIJKE PHILIPS N.V. 380
13.1.5.1 Business overview 380
13.1.5.2 Products offered 381
13.1.5.3 Recent developments 382
13.1.5.3.1 Product approvals 382
13.1.5.3.2 Deals 383
13.1.5.3.3 Expansions 383
13.1.5.4 MnM view 384
13.1.5.4.1 Right to win 384
13.1.5.4.2 Strategic choices 384
13.1.5.4.3 Weaknesses and competitive threats 384
13.1.6 TERUMO CORPORATION 385
13.1.6.1 Business overview 385
13.1.6.2 Products offered 386
13.1.6.3 Recent developments 387
13.1.6.3.1 Product launches 387
13.1.6.3.2 Deals 388
13.1.6.3.3 Expansions 389
13.1.7 MERIT MEDICAL SYSTEMS, INC. 390
13.1.7.1 Business overview 390
13.1.7.2 Products offered 391
13.1.7.3 Recent developments 392
13.1.7.3.1 Product launches 392
13.1.7.3.2 Deals 392

13.1.8 B. BRAUN SE 394
13.1.8.1 Business overview 394
13.1.8.2 Products offered 395
13.1.8.3 Recent developments 397
13.1.8.3.1 Product approvals 397
13.1.9 MEDTRONIC 398
13.1.9.1 Business overview 398
13.1.9.2 Products offered 399
13.1.9.3 Recent developments 401
13.1.9.3.1 Product launches and approvals 401
13.1.9.3.2 Deals 402
13.1.10 PENUMBRA, INC. 403
13.1.10.1 Business overview 403
13.1.10.2 Products offered 404
13.1.10.3 Recent developments 405
13.1.10.3.1 Product launches and approvals 405
13.1.11 STRYKER CORPORATION 406
13.1.11.1 Business overview 406
13.1.11.2 Products offered 407
13.1.11.3 Recent developments 408
13.1.11.3.1 Deals 408
13.1.12 CORDIS 409
13.1.12.1 Business overview 409
13.1.12.2 Products offered 409
13.1.12.3 Recent developments 411
13.1.12.3.1 Product approvals 411
13.1.12.3.2 Deals 411
13.1.13 COOK 412
13.1.13.1 Business overview 412
13.1.13.2 Products offered 412
13.1.13.3 Recent developments 414
13.1.13.3.1 Deals 414
13.1.14 W. L. GORE & ASSOCIATES, INC. 415
13.1.14.1 Business overview 415
13.1.14.2 Products offered 415
13.1.14.3 Recent developments 416
13.1.14.3.1 Product approvals 416
13.1.15 BIOSENSORS INTERNATIONAL GROUP, LTD. 417
13.1.15.1 Business overview 417
13.1.15.2 Products offered 417

13.1.16 IVASCULAR 418
13.1.16.1 Business overview 418
13.1.16.2 Products offered 418
13.1.17 BIOTRONIK 419
13.1.17.1 Business overview 419
13.1.17.2 Products offered 419
13.1.17.3 Recent developments 420
13.1.17.3.1 Product launches 420
13.1.18 ENDOLOGIX 421
13.1.18.1 Business overview 421
13.1.18.2 Products offered 421
13.1.19 ENDOCOR GMBH & CO., KG 422
13.1.19.1 Business overview 422
13.1.19.2 Products offered 422
13.2 OTHER PLAYERS 423
13.2.1 MERIL LIFE SCIENCES PVT. LTD. 423
13.2.2 ALVIMEDICA 424
13.2.3 CARDIONOVUM GMBH 425
13.2.4 SMT 425
13.2.5 MEDINOL 426
13.2.6 ANDRAMED GMBH 426
13.2.7 REX MEDICAL 427
13.2.8 QMD 427
13.2.9 BROSMED MEDICAL CO., LTD. 428
13.2.10 ELIXIR MEDICAL 428
14 RESEARCH METHODOLOGY 429
14.1 RESEARCH DATA 429
14.1.1 SECONDARY DATA 429
14.1.1.1 Key data from secondary sources 431
14.1.2 PRIMARY DATA 431
14.1.2.1 Key data from primary sources 433
14.1.2.2 Key industry insights 433
14.1.2.3 Key industry insights 434
14.2 MARKET SIZE ESTIMATION 435
14.3 GROWTH FORECAST 439
14.3.1 KEY INDUSTRY INSIGHTS 440
14.4 MARKET BREAKDOWN AND DATA TRIANGULATION 441
14.5 RESEARCH ASSUMPTIONS 442
14.6 RISK ASSESSMENT 442
14.7 RESEARCH LIMITATIONS 442
15 APPENDIX 443
15.1 DISCUSSION GUIDE 443
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 448
15.3 CUSTOMIZATION OPTIONS 450
15.3.1 PRODUCT ANALYSIS 450
15.3.2 US: END-USER ANALYSIS 450
15.3.3 GEOGRAPHIC ANALYSIS 450
15.3.4 COMPANY INFORMATION 450
15.3.5 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 450
15.3.6 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE 450
15.3.7 MARKET SHARE ANALYSIS, BY PRODUCT TYPE (TOP FIVE PLAYERS) 450
15.3.8 ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST 450
15.4 RELATED REPORTS 451
15.5 AUTHOR DETAILS 452

LIST OF TABLES

TABLE 1 INCLUSIONS & EXCLUSIONS 39
TABLE 2 STANDARD CURRENCY CONVERSION RATES 40
TABLE 3 GLOBAL GERIATRIC POPULATION TRENDS (2015 VS. 2030):
REGIONAL BREAKDOWN 51
TABLE 4 US: REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES, 2026 (USD) 52
TABLE 5 PRODUCT APPROVALS IN PERIPHERAL VASCULAR DEVICES MARKET, 2023–2024 52
TABLE 6 DIABETES POPULATION, BY REGION, 2024 VS. 2050 53
TABLE 7 TOP 10 COUNTRIES WITH HIGHEST SMOKING RATE, 2025 54
TABLE 8 OBESITY RATE IN DEVELOPING COUNTRIES, 2026 55
TABLE 9 PRODUCT FAILURES AND RECALLS 56
TABLE 10 UNMET NEEDS AND WHITE SPACES 59
TABLE 11 INTERCONNECTED MARKETS 60
TABLE 12 CROSS-SECTOR OPPORTUNITIES 60
TABLE 13 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61
TABLE 14 IMPACT OF PORTER’S FIVE FORCES ON PERIPHERAL VASCULAR DEVICES MARKET 62
TABLE 15 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER,
2023–2025 (USD) 72
TABLE 16 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023–2025 (USD) 72
TABLE 17 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 74
TABLE 18 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 76
TABLE 19 PERIPHERAL VASCULAR DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 77
TABLE 20 US ADJUSTED RECIPROCAL TARIFF RATES 81
TABLE 21 PERIPHERAL VASCULAR DEVICES MARKET: TECHNOLOGY/PRODUCT ROADMAP (2026–2035) 89
TABLE 22 PERIPHERAL VASCULAR DEVICES MARKET: LIST OF MAJOR PATENTS, JANUARY 2023–FEBRUARY 2026 92
TABLE 23 AI INTEGRATION: PERIPHERAL VASCULAR DEVICES MARKET 95
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 27 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 28 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIPHERAL VASCULAR DEVICES 103
TABLE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS 104
TABLE 31 PERIPHERAL VASCULAR DEVICES MARKET: UNMET NEEDS IN
KEY END-USE SETTINGS 106
TABLE 32 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 109
TABLE 33 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 110
TABLE 34 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 110
TABLE 35 ANGIOPLASTY STENTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 111
TABLE 36 DRUG-ELUTING STENTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 113
TABLE 37 BARE-METAL STENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 115
TABLE 38 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2024–2031 (USD MILLION) 116
TABLE 39 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 117
TABLE 40 SELF-EXPANDABLE STENTS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 119
TABLE 41 EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120
TABLE 42 EVAR STENT GRAFTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 121
TABLE 43 AAA STENT GRAFTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 123
TABLE 44 TAA STENT GRAFTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 125
TABLE 45 CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 126
TABLE 46 CATHETERS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 127
TABLE 47 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 129
TABLE 48 GUIDING CATHETERS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 131
TABLE 49 IVUS/OCT CATHETERS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 133
TABLE 50 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134
TABLE 51 INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 135
TABLE 52 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 137
TABLE 53 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 139
TABLE 54 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 55 ANGIOPLASTY BALLOONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 141
TABLE 56 OLD/NORMAL BALLOONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 143
TABLE 57 DRUG-ELUTING BALLOONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 145
TABLE 58 CUTTING & SCORING BALLOONS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 147
TABLE 59 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 60 PLAQUE MODIFICATION DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 149
TABLE 61 ATHERECTOMY DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 151
TABLE 62 THROMBECTOMY DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 153
TABLE 63 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 154
TABLE 64 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 155
TABLE 65 EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 157
TABLE 66 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 159
TABLE 67 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 160
TABLE 68 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 161
TABLE 69 GUIDEWIRES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 163
TABLE 70 VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 165
TABLE 71 INTRODUCER SHEATHS MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 167
TABLE 72 BALLOON INFLATION DEVICES MARKET, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 169
TABLE 73 PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 171
TABLE 74 PERIPHERAL VASCULAR DEVICES MARKET FOR HOSPITALS, BY TYPE,
2024–2031 (USD MILLION) 172
TABLE 75 PERIPHERAL VASCULAR DEVICES MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 173
TABLE 76 PERIPHERAL VASCULAR DEVICES MARKET FOR LARGE CHAIN HOSPITALS,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 175
TABLE 77 PERIPHERAL VASCULAR DEVICES MARKET FOR STANDALONE HOSPITAL FACILITIES SEGMENT, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 177
TABLE 78 PERIPHERAL VASCULAR DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 179
TABLE 79 PERIPHERAL VASCULAR DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2024–2031 (USD MILLION) 181
TABLE 80 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2024–2031 (USD MILLION) 183
TABLE 81 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 185
TABLE 82 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 185
TABLE 83 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 186
TABLE 84 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (THOUSAND UNITS) 186
TABLE 85 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 186
TABLE 86 NORTH AMERICA: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 187
TABLE 87 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 187
TABLE 88 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 187
TABLE 89 NORTH AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 90 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 91 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 188
TABLE 92 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 93 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 189
TABLE 94 NORTH AMERICA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 95 US: MACROECONOMIC INDICATORS 190
TABLE 96 US: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 191
TABLE 97 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 191
TABLE 98 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 99 US: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 100 US: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 101 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 193
TABLE 102 US: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 193
TABLE 103 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 193
TABLE 104 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 105 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 106 US: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 194
TABLE 107 US: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 108 CANADA: MACROECONOMIC INDICATORS 195
TABLE 109 CANADA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 196
TABLE 110 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 111 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 112 CANADA: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 113 CANADA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 114 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 115 CANADA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 198
TABLE 116 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 198
TABLE 117 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 118 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 119 CANADA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 199
TABLE 120 CANADA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 121 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 201
TABLE 122 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 201
TABLE 123 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 124 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (THOUSAND UNITS) 202
TABLE 125 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 126 EUROPE: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 127 EUROPE: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 128 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 129 EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 130 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 131 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 132 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 133 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 205
TABLE 134 EUROPE: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205
TABLE 135 GERMANY: MACROECONOMIC INDICATORS 206
TABLE 136 GERMANY: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 207
TABLE 137 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 138 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 139 GERMANY: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 140 GERMANY: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 141 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 142 GERMANY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 143 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 144 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 145 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 146 GERMANY: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 210
TABLE 147 GERMANY: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 148 FRANCE: MACROECONOMIC INDICATORS 211
TABLE 149 FRANCE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 212
TABLE 150 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 151 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 152 FRANCE: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 153 FRANCE: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 154 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 155 FRANCE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 156 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 157 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 158 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 159 FRANCE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 215
TABLE 160 FRANCE: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 161 UK: MACROECONOMIC INDICATORS 216
TABLE 162 UK: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 217
TABLE 163 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 164 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 165 UK: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 166 UK: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 167 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 168 UK: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 169 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 170 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 171 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 172 UK: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 220
TABLE 173 UK: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 174 SPAIN: MACROECONOMIC INDICATORS 222
TABLE 175 SPAIN: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 222
TABLE 176 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 177 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 178 SPAIN: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 179 SPAIN: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 180 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 181 SPAIN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 182 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 183 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 184 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 185 SPAIN: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 226
TABLE 186 SPAIN: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 187 ITALY: MACROECONOMIC INDICATORS 227
TABLE 188 ITALY: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 227
TABLE 189 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 190 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 191 ITALY: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 192 ITALY: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 193 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 194 ITALY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 195 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 196 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 197 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 198 ITALY: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 231
TABLE 199 ITALY: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 200 REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 232
TABLE 201 REST OF EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 232
TABLE 202 REST OF EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 203 REST OF EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 204 REST OF EUROPE: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 205 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 206 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 234
TABLE 207 REST OF EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 234
TABLE 208 REST OF EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 209 REST OF EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 210 REST OF EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 211 REST OF EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 236
TABLE 212 REST OF EUROPE: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 213 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 238
TABLE 214 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 238
TABLE 215 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 216 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (THOUSAND UNITS) 239
TABLE 217 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 218 ASIA PACIFIC: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 219 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 220 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 221 ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 222 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 223 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 224 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 225 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 242
TABLE 226 ASIA PACIFIC: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 227 JAPAN: MACROECONOMIC INDICATORS 243
TABLE 228 JAPAN: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 244
TABLE 229 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 230 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 231 JAPAN: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 232 JAPAN: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 233 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 234 JAPAN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 246
TABLE 235 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 246
TABLE 236 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 247
TABLE 237 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 247
TABLE 238 JAPAN: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 247
TABLE 239 JAPAN: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 240 CHINA: MACROECONOMIC INDICATORS 248
TABLE 241 CHINA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 249
TABLE 242 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 243 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 244 CHINA: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 245 CHINA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 246 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 247 CHINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 248 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 249 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 250 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 251 CHINA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 252
TABLE 252 CHINA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 253 INDIA: MACROECONOMIC INDICATORS 253
TABLE 254 INDIA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 254
TABLE 255 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 256 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 257 INDIA: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 258 INDIA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 259 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 260 INDIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 256
TABLE 261 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 256
TABLE 262 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 263 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 264 INDIA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 257
TABLE 265 INDIA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 266 AUSTRALIA: MACROECONOMIC INDICATORS 258
TABLE 267 AUSTRALIA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 259
TABLE 268 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 269 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 270 AUSTRALIA: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 271 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 272 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 273 AUSTRALIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 274 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 275 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 262
TABLE 276 AUSTRALIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 277 AUSTRALIA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 262
TABLE 278 AUSTRALIA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 279 SOUTH KOREA: MACROECONOMIC INDICATORS 263
TABLE 280 SOUTH KOREA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 264
TABLE 281 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 282 SOUTH KOREA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 265
TABLE 283 SOUTH KOREA: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 265
TABLE 284 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 285 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 286 SOUTH KOREA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 287 SOUTH KOREA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 288 SOUTH KOREA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 289 SOUTH KOREA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 290 SOUTH KOREA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 267
TABLE 291 SOUTH KOREA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 292 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 268
TABLE 293 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 269
TABLE 294 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 269
TABLE 295 REST OF ASIA PACIFIC: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 269
TABLE 296 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 297 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 298 REST OF ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 299 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 300 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 301 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 302 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 272
TABLE 303 REST OF ASIA PACIFIC: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 304 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 273
TABLE 305 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 274
TABLE 306 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 274
TABLE 307 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (THOUSAND UNITS) 275
TABLE 308 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 309 LATIN AMERICA: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 310 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 311 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 312 LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 313 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 277
TABLE 314 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 315 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 316 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 278
TABLE 317 LATIN AMERICA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 318 BRAZIL: MACROECONOMIC INDICATORS 279
TABLE 319 BRAZIL: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 279
TABLE 320 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 321 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 322 BRAZIL: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 323 BRAZIL: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 324 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 325 BRAZIL: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 281
TABLE 326 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 327 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 328 BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 329 BRAZIL: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 283
TABLE 330 BRAZIL: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 331 MEXICO: MACROECONOMIC INDICATORS 284
TABLE 332 MEXICO: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 284
TABLE 333 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 334 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 335 MEXICO: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 336 MEXICO: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 337 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 338 MEXICO: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 286
TABLE 339 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 340 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 341 MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 342 MEXICO: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 288
TABLE 343 MEXICO: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 344 COLOMBIA: MACROECONOMIC INDICATORS 289
TABLE 345 COLOMBIA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 289
TABLE 346 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 290
TABLE 347 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 348 COLOMBIA: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 349 COLOMBIA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 350 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 351 COLOMBIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 291
TABLE 352 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 353 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 354 COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 355 COLOMBIA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 293
TABLE 356 COLOMBIA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 357 ARGENTINA: MACROECONOMIC INDICATORS 294
TABLE 358 ARGENTINA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 294
TABLE 359 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 295
TABLE 360 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 361 ARGENTINA: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 362 ARGENTINA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 363 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 364 ARGENTINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 296
TABLE 365 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 366 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 367 ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 368 ARGENTINA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 298
TABLE 369 ARGENTINA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 370 REST OF LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 299
TABLE 371 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 299
TABLE 372 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 300
TABLE 373 REST OF LATIN AMERICA: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 300
TABLE 374 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 300
TABLE 375 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 301
TABLE 376 REST OF LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 301
TABLE 377 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 378 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 379 REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 380 REST OF LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 302
TABLE 381 REST OF LATIN AMERICA: HOSPITALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 303
TABLE 382 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 304
TABLE 383 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 304
TABLE 384 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 385 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (THOUSAND UNITS) 305
TABLE 386 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 387 MIDDLE EAST & AFRICA: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 388 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 389 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 306
TABLE 390 MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 307
TABLE 391 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 392 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 393 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 394 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 308
TABLE 395 MIDDLE EAST & AFRICA: HOSPITALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 308
TABLE 396 GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 309
TABLE 397 GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 310
TABLE 398 GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 310
TABLE 399 GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 311
TABLE 400 GCC COUNTRIES: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 311
TABLE 401 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 402 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 312
TABLE 403 GCC COUNTRIES: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 312
TABLE 404 GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 312
TABLE 405 GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 406 GCC COUNTRIES: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 407 GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 313
TABLE 408 GCC COUNTRIES: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 409 KSA: MACROECONOMIC INDICATORS 314
TABLE 410 KSA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 315
TABLE 411 KSA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 412 KSA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316
TABLE 413 KSA: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316
TABLE 414 KSA: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 316
TABLE 415 KSA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 416 KSA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 317
TABLE 417 KSA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 317
TABLE 418 KSA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 318
TABLE 419 KSA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 318
TABLE 420 KSA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 318
TABLE 421 KSA: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 422 UAE: MACROECONOMIC INDICATORS 319
TABLE 423 UAE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE,
2024–2031 (USD MILLION) 320
TABLE 424 UAE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 320
TABLE 425 UAE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 426 UAE: BARE-METAL STENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 427 UAE: CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 428 UAE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 429 UAE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 430 UAE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 322
TABLE 431 UAE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 323
TABLE 432 UAE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 323
TABLE 433 UAE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 323
TABLE 434 UAE: HOSPITALS MARKET, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 435 REST OF GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 324
TABLE 436 REST OF GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 325
TABLE 437 REST OF GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 325
TABLE 438 REST OF GCC COUNTRIES: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 325
TABLE 439 REST OF GCC COUNTRIES: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 326
TABLE 440 REST OF GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 326
TABLE 441 REST OF GCC COUNTRIES: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 326
TABLE 442 REST OF GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 443 REST OF GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 444 REST OF GCC COUNTRIES: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 445 REST OF GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 328
TABLE 446 REST OF GCC COUNTRIES: HOSPITALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 328
TABLE 447 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET,
BY PRODUCT TYPE, 2024–2031 (USD MILLION) 329
TABLE 448 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 449 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 330
TABLE 450 REST OF MIDDLE EAST & AFRICA: BARE-METAL STENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 330
TABLE 451 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 330
TABLE 452 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 331
TABLE 453 REST OF MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 454 REST OF MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 455 REST OF MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 456 REST OF MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 457 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 332
TABLE 458 REST OF MIDDLE EAST & AFRICA: HOSPITALS MARKET, BY TYPE,
2024–2031 (USD MILLION) 333
TABLE 459 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET 334
TABLE 460 PERIPHERAL VASCULAR DEVICES MARKET: DEGREE OF COMPETITION 337
TABLE 461 PERIPHERAL VASCULAR DEVICES MARKET: REGIONAL FOOTPRINT, 2025 342
TABLE 462 PERIPHERAL VASCULAR DEVICES MARKET: PRODUCT TYPE FOOTPRINT, 2025 343
TABLE 463 PERIPHERAL VASCULAR DEVICES MARKET: END USER FOOTPRINT, 2025 344
TABLE 464 PERIPHERAL VASCULAR DEVICES MARKET: KEY STARTUPS/SMES, 2025 347
TABLE 465 PERIPHERAL VASCULAR DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025 348
TABLE 466 PERIPHERAL VASCULAR DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MARCH 2026 351
TABLE 467 PERIPHERAL VASCULAR DEVICES MARKET: DEALS, JANUARY 2023–MARCH 2026 352
TABLE 468 PERIPHERAL VASCULAR DEVICES MARKET: EXPANSIONS,
JANUARY 2023–MARCH 2026 353
TABLE 469 PERIPHERAL VASCULAR DEVICES MARKET: OTHER DEVELOPMENTS,
JANUARY 2023–MARCH 2026 354
TABLE 470 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 355
TABLE 471 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 356
TABLE 472 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS 358
TABLE 473 BOSTON SCIENTIFIC CORPORATION: DEALS 359
TABLE 474 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS 360
TABLE 475 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 361
TABLE 476 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 362
TABLE 477 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS 364
TABLE 478 BECTON, DICKINSON AND COMPANY: DEALS 365
TABLE 479 BECTON, DICKINSON AND COMPANY: EXPANSIONS 366
TABLE 480 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS 366
TABLE 481 ABBOTT LABORATORIES: COMPANY OVERVIEW 368
TABLE 482 ABBOTT LABORATORIES: PRODUCTS OFFERED 369
TABLE 483 ABBOTT LABORATORIES: PRODUCT LAUNCHES 371
TABLE 484 ABBOTT LABORATORIES: DEALS 372
TABLE 485 ABBOTT LABORATORIES: EXPANSIONS 372
TABLE 486 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 374
TABLE 487 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 375
TABLE 488 CARDINAL HEALTH, INC.: PRODUCT LAUNCHES 377
TABLE 489 CARDINAL HEALTH, INC.: DEALS 377
TABLE 490 CARDINAL HEALTH, INC.: EXPANSIONS 378
TABLE 491 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 380
TABLE 492 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 381
TABLE 493 KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS 382
TABLE 494 KONINKLIJKE PHILIPS N.V.: DEALS 383
TABLE 495 KONINKLIJKE PHILIPS N.V.: EXPANSIONS 383
TABLE 496 TERUMO CORPORATION: COMPANY OVERVIEW 385
TABLE 497 TERUMO CORPORATION: PRODUCTS OFFERED 386
TABLE 498 TERUMO CORPORATION: PRODUCT LAUNCHES 387
TABLE 499 TERUMO CORPORATION: DEALS 388
TABLE 500 TERUMO CORPORATION: EXPANSIONS 389
TABLE 501 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 390
TABLE 502 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 391
TABLE 503 MERIT MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES 392
TABLE 504 MERIT MEDICAL SYSTEMS, INC.: DEALS 392
TABLE 505 B. BRAUN SE: COMPANY OVERVIEW 394
TABLE 506 B. BRAUN SE: PRODUCTS OFFERED 395
TABLE 507 B. BRAUN SE: PRODUCT APPROVALS 397
TABLE 508 MEDTRONIC: COMPANY OVERVIEW 398
TABLE 509 MEDTRONIC: PRODUCTS OFFERED 399
TABLE 510 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS 401
TABLE 511 MEDTRONIC: DEALS 402
TABLE 512 PENUMBRA, INC.: COMPANY OVERVIEW 403
TABLE 513 PENUMBRA, INC.: PRODUCTS OFFERED 404
TABLE 514 PENUMBRA, INC.: PRODUCT LAUNCHES AND APPROVALS 405
TABLE 515 STRYKER CORPORATION: COMPANY OVERVIEW 406
TABLE 516 STRYKER CORPORATION: PRODUCTS OFFERED 407
TABLE 517 STRYKER CORPORATION: DEALS 408
TABLE 518 CORDIS: COMPANY OVERVIEW 409
TABLE 519 CORDIS: PRODUCTS OFFERED 409
TABLE 520 CORDIS: PRODUCT APPROVALS 411
TABLE 521 CORDIS: DEALS 411
TABLE 522 COOK: COMPANY OVERVIEW 412
TABLE 523 COOK: PRODUCTS OFFERED 412
TABLE 524 COOK: DEALS 414
TABLE 525 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 415
TABLE 526 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED 415
TABLE 527 W. L. GORE & ASSOCIATES, INC: PRODUCT APPROVALS 416
TABLE 528 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW 417
TABLE 529 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED 417
TABLE 530 IVASCULAR: COMPANY OVERVIEW 418
TABLE 531 IVASCULAR: PRODUCTS OFFERED 418
TABLE 532 BIOTRONIK: COMPANY OVERVIEW 419
TABLE 533 BIOTRONIK: PRODUCTS OFFERED 419
TABLE 534 BIOTRONIK: PRODUCT LAUNCHES 420
TABLE 535 ENDOLOGIX: COMPANY OVERVIEW 421
TABLE 536 ENDOLOGIX: PRODUCTS OFFERED 421
TABLE 537 ENDOCOR GMBH & CO., KG: COMPANY OVERVIEW 422
TABLE 538 ENDOCOR GMBH & CO., KG: PRODUCTS OFFERED 422
TABLE 539 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 423
TABLE 540 ALVIMEDICA: COMPANY OVERVIEW 424
TABLE 541 CARDIONOVUM GMBH: COMPANY OVERVIEW 425
TABLE 542 SMT: COMPANY OVERVIEW 425
TABLE 543 MEDINOL: COMPANY OVERVIEW 426
TABLE 544 ANDRAMED GMBH: COMPANY OVERVIEW 426
TABLE 545 REX MEDICAL: COMPANY OVERVIEW 427
TABLE 546 QMD: COMPANY OVERVIEW 427
TABLE 547 BROSMED MEDICAL CO., LTD.: COMPANY OVERVIEW 428
TABLE 548 ELIXIR MEDICAL: COMPANY OVERVIEW 428

LIST OF FIGURES

FIGURE 1 MARKETS COVERED 38
FIGURE 2 STUDY YEARS 39
FIGURE 3 MARKET SCENARIO 42
FIGURE 4 GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, 2024–2031 43
FIGURE 5 PERIPHERAL VASCULAR DEVICES MARKET: MAJOR STRATEGIES ADOPTED
BY KEY PLAYERS, 2022–2025 43
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PERIPHERAL VASCULAR
DEVICES MARKET 44
FIGURE 7 PERIPHERAL VASCULAR DEVICES MARKET: HIGH-GROWTH SEGMENTS,
2026–2031 45
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PERIPHERAL VASCULAR DEVICES MARKET DURING FORECAST PERIOD 46
FIGURE 9 RISING PREVALENCE OF PERIPHERAL ARTERY DISEASE (PAD) TO DRIVE MARKET 47
FIGURE 10 ANGIOPLASTY STENT PRODUCTS AND CHINA LED RESPECTIVE MARKET SEGMENTS IN 2025 48
FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 49
FIGURE 12 INDIA TO REGISTER HIGHER GROWTH RATES THAN EMERGING ECONOMIES DURING FORECAST PERIOD 49
FIGURE 13 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 14 PERIPHERAL VASCULAR DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 63
FIGURE 15 PERIPHERAL VASCULAR DEVICES MARKET: SUPPLY CHAIN 69
FIGURE 16 PERIPHERAL VASCULAR DEVICES MARKET: VALUE CHAIN ANALYSIS (2025) 70
FIGURE 17 PERIPHERAL VASCULAR DEVICES MARKET: ECOSYSTEM ANALYSIS 71
FIGURE 18 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 74
FIGURE 19 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 75
FIGURE 20 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 78
FIGURE 21 INVESTMENT/VENTURE CAPITAL SCENARIO IN PERIPHERAL VASCULAR DEVICES MARKET, 2021–2025 79
FIGURE 22 PATENTS APPLIED AND GRANTED, 2015–2025 91
FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR PERIPHERAL VASCULAR PATENTS, 2015–2025 92
FIGURE 24 PERIPHERAL VASCULAR DEVICES MARKET: DECISION-MAKING FACTORS 102
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIPHERAL VASCULAR DEVICES 103
FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS 104
FIGURE 27 ADOPTION BARRIERS AND INTERNAL CHALLENGES 105
FIGURE 28 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT 184
FIGURE 29 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT 237
FIGURE 30 REVENUE ANALYSIS FOR KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET, 2023–2025 (USD MILLION) 336

FIGURE 31 GLOBAL SHARE ANALYSIS OF KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET, 2025 337
FIGURE 32 US: PERIPHERAL VASCULAR DEVICES MARKET SHARE ANALYSIS, 2025 339
FIGURE 33 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 340
FIGURE 34 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY FOOTPRINT, 2025 341
FIGURE 35 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 346
FIGURE 36 PERIPHERAL VASCULAR DEVICES MARKET: BRAND/PRODUCT
COMPARATIVE ANALYSIS 349
FIGURE 37 EV/EBITDA OF KEY VENDORS, 2024 349
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS, 2024 350
FIGURE 39 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT, 2025 356
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT, 2025 362
FIGURE 41 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2025 369
FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT, 2025 375
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT, 2025 381
FIGURE 44 TERUMO CORPORATION: COMPANY SNAPSHOT, 2025 386
FIGURE 45 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT, 2025 391
FIGURE 46 B. BRAUN SE: COMPANY SNAPSHOT, 2025 395
FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT, 2025 399
FIGURE 48 PENUMBRA, INC.: COMPANY SNAPSHOT, 2025 404
FIGURE 49 STRYKER CORPORATION: COMPANY SNAPSHOT, 2025 407
FIGURE 50 RESEARCH DESIGN 429
FIGURE 51 PRIMARY SOURCES 432
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 433
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS 434
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 434
FIGURE 55 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 435
FIGURE 56 BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE ANALYSIS (2025) 436
FIGURE 57 PERIPHERAL VASCULAR DEVICES MARKET: SUPPLY-SIDE ANALYSIS 436
FIGURE 58 TOP-DOWN APPROACH 437
FIGURE 59 CAGR PROJECTIONS FROM ANALYSIS OF PERIPHERAL VASCULAR DEVICES MARKET DYNAMICS, 2026–2031 438
FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF PERIPHERAL
VASCULAR DEVICES MARKET, 2026–2031 439
FIGURE 61 DATA TRIANGULATION 441

---

---